Dissected peripancreatic tissue margin is a critical prognostic factor and is associated with a K‑ras gene mutation in pancreatic ductal adenocarcinoma

作者: Nobuyuki Nishizawa , Yusuke Kumamoto , Hiroshi Katoh , Hideki Ushiku , Keigo Yokoi

DOI: 10.3892/OL.2018.9839

关键词: Proportional hazards modelOncologyMolecular medicineCancerOncogeneInternal medicinePancreatectomyStage (cooking)MedicineGene mutationPropensity score matching

摘要: We previously reported that the dissected pancreatic tissue margin (DPM) and preoperative serum level of carbohydrate antigen 19-9 (preCA19-9) were independent prognostic factors in ductal adenocarcinoma (PDAC). In current study, relevance these factors, including their molecular associations, validated. A total 161 patients with PDAC underwent a pancreatectomy between 1986 2013, multivariate Cox proportional hazards model propensity score-based validated importance DPM. The compared mutation profiles K-ras TP53 genes. Univariate analysis disease-specific survival (DSS) demonstrated DPM (P<0.0001), preCA19-9 (P<0.0001) Union for International Cancer Control (UICC) stage all significantly associated poor outcome PDAC. confirmed (P=0.0002) remained as UICC (P=0.0015). combination to predict prognosis could accurately identify long-term survivors (70% 5-year DSS), logistic regression identified was most effective predictor mortality. also (P=0.0008) through background adjustment patient bias. gene (P=0.0002), DPM-positive recurrence distant metastasis 67% cases. Therefore, is critical indicator preCA19-9, may be useful Furthermore, best our knowledge, study first discover can represent based putatively on its association mutation.

参考文章(34)
Riccardo Piagnerelli, Daniele Marrelli, Giandomenico Roviello, Francesco Ferrara, Giulio Di Mare, Costantino Voglino, Roberto Petrioli, Mario Marini, Raffaele Macchiarelli, Franco Roviello, Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas Tumor Biology. ,vol. 37, pp. 1959- 1966 ,(2016) , 10.1007/S13277-015-3986-X
Edward J. Kim, Edgar Ben-Josef, Joseph M. Herman, Tanios Bekaii-Saab, Laura A. Dawson, Kent A. Griffith, Isaac R. Francis, Joel K. Greenson, Diane M. Simeone, Theodore S. Lawrence, Daniel Laheru, Christopher L. Wolfgang, Terence Williams, Mark Bloomston, Malcolm J. Moore, Alice Wei, Mark M. Zalupski, A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer Cancer. ,vol. 119, pp. 2692- 2700 ,(2013) , 10.1002/CNCR.28117
Hiroshi Kawamata, Keishi Yamashita, Ken Kojo, Hideki Ushiku, Akira Ooki, Masahiko Watanabe, Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13 Genomics. ,vol. 106, pp. 71- 75 ,(2015) , 10.1016/J.YGENO.2015.05.007
Tsutomu Yoshida, Kazuya Yamashita, Hiroshi Shinoda, Isao Okayasu, Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections. Archives of Pathology & Laboratory Medicine. ,vol. 125, pp. 347- 352 ,(2001) , 10.5858/2001-125-0347-NMFSAO
Mina Waraya, Keishi Yamashita, Hiroyuki Katagiri, Kenichiro Ishii, Yoshihito Takahashi, Kazunori Furuta, Masahiko Watanabe, Preoperative Serum CA19-9 and Dissected Peripancreatic Tissue Margin as Determiners of Long-Term Survival in Pancreatic Cancer Annals of Surgical Oncology. ,vol. 16, pp. 1231- 1240 ,(2009) , 10.1245/S10434-009-0415-7
Lola Rahib, Benjamin D. Smith, Rhonda Aizenberg, Allison B. Rosenzweig, Julie M. Fleshman, Lynn M. Matrisian, Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States Cancer Research. ,vol. 74, pp. 2913- 2921 ,(2014) , 10.1158/0008-5472.CAN-14-0155
J. Hein Allema, Marcel E. Reinders, Thomas M. van Gulik, Mark J. W. Koelemay, Dirk J. van Leeuwen, Laurens Th. de Wit, Dirk J. Gouma, Huug Obertop, Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region Cancer. ,vol. 75, pp. 2069- 2076 ,(1995) , 10.1002/1097-0142(19950415)75:8<2069::AID-CNCR2820750807>3.0.CO;2-7
Wataru Onozato, Keishi Yamashita, Kazuya Yamashita, Tatsuru Kuba, Hiroshi Katoh, Takatoshi Nakamura, Takeo Sato, Atsushi Ihara, Isao Okayasu, Masahiko Watanabe, Genetic alterations of K-ras may reflect prognosis in stage III colon cancer patients below 60 years of age. Journal of Surgical Oncology. ,vol. 103, pp. 25- 33 ,(2011) , 10.1002/JSO.21710
Kazuya Yamashita, Yoshiki Kida, Hiroshi Shinoda, Mituhiro Kida, Isao Okayasu, k-rasPoint Mutations in the Supernatants of Pancreatic Juice and Bile Are Reliable for Diagnosis of Pancreas and Biliary Tract Carcinomas Complementary to Cytologic Examination Japanese Journal of Cancer Research. ,vol. 90, pp. 240- 248 ,(1999) , 10.1111/J.1349-7006.1999.TB00739.X
N Knijn, L J M Mekenkamp, M Klomp, M E Vink-Börger, J Tol, S Teerenstra, J W R Meijer, M Tebar, S Riemersma, J H J M van Krieken, C J A Punt, I D Nagtegaal, KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients British Journal of Cancer. ,vol. 104, pp. 1020- 1026 ,(2011) , 10.1038/BJC.2011.26